- Alnylam Pharmaceuticals ( NASDAQ: ALNY ) is scheduled to announce Q2 earnings results on Thursday, July 28th, before market open.
- The consensus EPS Estimate is -$1.34 (-3.1% Y/Y) and the consensus Revenue Estimate is $256.06M (+16.1% Y/Y).
- Over the last 2 years, ALNY has beaten EPS estimates 0% of the time and has beaten revenue estimates 75% of the time.
- Over the last 3 months, EPS estimates have seen 4 upward revisions and 3 downward. Revenue estimates have seen 0 upward revisions and 15 downward.
For further details see:
Alnylam Pharmaceuticals Q2 2022 Earnings Preview